Biogenesis of Organelles and Membrane Proteins. [PDF]
Harmey, Matthew A.+3 more
core +1 more source
Comprehensive multicentre retrospective analysis for predicting isocitrate dehydrogenase-mutant lower-grade gliomas. [PDF]
Zhao D+12 more
europepmc +1 more source
Isocitrate Dehydrogenase 2 (IDH2)-Mutant Metastatic Esthesioneuroblastoma: A Case Report and Review of Current Therapeutic Options. [PDF]
Banha R+3 more
europepmc +1 more source
Enzyme response to thyrotoxicosis and hypothyroidism in human liver and muscle [PDF]
Bachmaier, B.+5 more
core
Prediction of isocitrate dehydrogenase mutation status in WHO grade II glioma by diffusion kurtosis imaging. [PDF]
Wu W, Zhang H.
europepmc +1 more source
Acute myeloid leukemia treatment outcomes with isocitrate dehydrogenase mutations: A systematic review and meta-analysis. [PDF]
Qin H, Xu R, Yang Y.
europepmc +1 more source
Clinical Implications of Isocitrate Dehydrogenase Mutations and Targeted Treatment of Acute Myeloid Leukemia with Mutant Isocitrate Dehydrogenase Inhibitors-Recent Advances, Challenges and Future Prospects. [PDF]
Kowalczyk A+4 more
europepmc +1 more source
Magnetic resonance diffusion-derived vessel density (DDVD) as a valuable tissue perfusion biomarker for isocitrate dehydrogenase genotyping in diffuse gliomas. [PDF]
Ni CX+9 more
europepmc +1 more source
Isocitrate dehydrogenase 1 and 2 mutations induce BCL-2 dependence in acute myeloid leukemia
Steven M. Chan+9 more
semanticscholar +1 more source
Repurposing the anthelmintic drug mebendazole in combination with radiation therapy in an isocitrate dehydrogenase mutant glioma model. [PDF]
Yamashita AS+2 more
europepmc +1 more source